We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CADL icon
4126
Candel Therapeutics
CADL
$780M
$10.4K ﹤0.01%
8,262
+1,686
+26% +$2.49K
WHWK
4127
Whitehawk Therapeutics
WHWK
$266M
$10.4K ﹤0.01%
1,520
+392
+35% +$3.05K
TARK icon
4128
Tradr 2X Long Innovation ETF
TARK
$16.1M
$10.4K ﹤0.01%
282
-1,414
-83% -$43.2K
GBTG icon
4129
American Express Global Business Travel
GBTG
$4.93B
$10.4K ﹤0.01%
+1,435
New +$9.78K
THRN
4130
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$10.4K ﹤0.01%
2,207
-231
-9% -$1.06K
ARL icon
4131
American Realty Investors
ARL
$246M
$10.4K ﹤0.01%
476
+60
+14% +$1.15K
IHG icon
4132
InterContinental Hotels
IHG
$23B
$10.4K ﹤0.01%
147
-815
-85% -$56K
EML icon
4133
Eastern Company
EML
$147M
$10.3K ﹤0.01%
572
-59
-9% -$1.04K
SER icon
4134
Serina Therapeutics
SER
$41.7M
$10.3K ﹤0.01%
329
-56
-15% -$1.2K
MITQ icon
4135
Moving iMage Technologies
MITQ
$5.34M
$10.3K ﹤0.01%
8,829
-3,198
-27% -$3.35K
CFB
4136
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$10.3K ﹤0.01%
1,030
-1,306
-56% -$13.5K
WLMS
4137
DELISTED
Williams Industrial Services Group Inc.
WLMS
$10.3K ﹤0.01%
27,073
+17,710
+189% +$12.4K
UNTY icon
4138
Unity Bancorp
UNTY
$609M
$10.3K ﹤0.01%
436
-42
-9% -$953
ELMD icon
4139
Electromed
ELMD
$351M
$10.3K ﹤0.01%
960
-94
-9% -$1.06K
ERAS icon
4140
Erasca
ERAS
$6.36B
$10.3K ﹤0.01%
3,724
-7,802
-68% -$22.2K
CUE icon
4141
Cue Biopharma
CUE
$119M
$10.3K ﹤0.01%
+94
New +$11K
SSKN
4142
DELISTED
Strata Skin Sciences
SSKN
$10.3K ﹤0.01%
1,080
-35
-3% -$345
SYRE icon
4143
Spyre Therapeutics
SYRE
$9.06B
$10.3K ﹤0.01%
910
-585
-39% -$2.77K
AP icon
4144
Ampco-Pittsburgh
AP
$202M
$10.3K ﹤0.01%
3,226
+2,120
+192% +$6.3K
BVH
4145
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$10.2K ﹤0.01%
287
-627
-69% -$18.8K
POCI icon
4146
Precision Optics
POCI
$46.4M
$10.2K ﹤0.01%
1,660
-736
-31% -$4.71K
CCVI.U
4147
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$10.2K ﹤0.01%
987
LBC
4148
DELISTED
Luther Burbank Corporation Common Stock
LBC
$10.2K ﹤0.01%
1,142
-1,035
-48% -$9.38K
IHS icon
4149
IHS Holding
IHS
$2.81B
$10.2K ﹤0.01%
1,041
-4,535
-81% -$39.9K
CTOS icon
4150
Custom Truck One Source
CTOS
$2.42B
$10.2K ﹤0.01%
1,510
-1,068
-41% -$7.03K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.